Dermatopathology Uncovered: Diagnostic Pearls from UT MD Anderson Cancer Center

---

LIVE

Friday, February 19, 2027, 4:00 PM - Saturday, February 20, 2027, 4:05 PM, UT MD Anderson - Main Building, Hickey Auditorium (R11.1400), Houston, TX


AMA PRA Category 1 Credits™ (7.75 hours), ABPath MOC Part II (7.75 hours), Non-Physician Attendance (7.75 hours)

Join us for an immersive dermatopathology conference at UT MD Anderson. This course highlights our institution’s multidisciplinary approach to dermatopathology, showcasing how complex cases are evaluated, diagnosed, and managed in collaboration with related specialties. Through case-based discussions and expert insights, attendees will gain practical perspectives on diagnostic challenges, clinical-pathologic correlation, and best practices.

1. Recognize and distinguish key histopathologic features, diagnostic mimics, and potential pitfalls encountered in common and challenging cutaneous diseases and neoplasms, including melanocytic, keratinocytic, adnexal, and hematolymphoid processes.
2. Apply practical diagnostic approaches to the evaluation of skin biopsies, integrating clinical context and histopathologic findings to develop appropriate differential diagnoses and improve diagnostic decision-making.
3. Recognize histopathologic patterns and diagnostic clues associated with infectious diseases and evolving patterns of drug-related adverse cutaneous reactions, particularly in patients with cancer.
4. Integrate clinical, histopathologic, immunophenotypic, and molecular information into the evaluation of cutaneous neoplasms and identify appropriate applications of ancillary and molecular testing.
5. Evaluate the role of dermatopathology in contemporary multidisciplinary cancer care, including the diagnostic information needed to support oncologic decision-making and the evaluation of patients receiving immunotherapy and precision medicine.
6. Apply contemporary diagnostic criteria, evidence-based approaches, and practical lessons from challenging cases to dermatopathology cases encountered in clinical practice.

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)

• Check made payable to: The University of Texas MD Anderson Cancer Center (payable through U.S. banks only)

Mail to:

Continuing Professional Education – Unit 1781
The University of Texas MD Anderson Cancer Center
 P.O. Box 301407
 Houston, Texas 77230-1407
Telephone registrations are not accepted

When registering online a receipt (confirmation) will be automatically emailed to the e-mail address you list on the registration form.

Refund/Cancellation Policy: The registration fee, minus a $50.00 administration-handling fee, is refundable if a written request is received on or before Friday, January 22, 2027.  No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.

The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of CPE, is limited to the registration fee.  CPE, will refund the full registration fee. CPE reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

For additional information, contact CPE, at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].

Special Assistance
Contact CPE, at 713-792-2223 or toll free at 866-849-5866 if you have any ADA accommodation needs.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

 

You are not logged in.

Please click the button below to login or create a new account before continuing.

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the educational content of a certified continuing education (CE) activity, including faculty, planners, reviewers, are required to disclose all financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used on or by patients. All relevant financial relationships have been mitigated prior to the start of the activity.